These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8732163)

  • 61. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
    Yamaguchi T; Okada T; Takeuchi K; Tonda T; Ohtaki M; Shinoda S; Masuzawa T; Ozawa K; Inaba T
    Gene Ther; 2003 Mar; 10(5):375-85. PubMed ID: 12601392
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
    Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Water diffusion in a rat glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death in vivo: correlation with cell density.
    Valonen PK; Lehtimäki KK; Väisänen TH; Kettunen MI; Gröhn OH; Ylä-Herttuala S; Kauppinen RA
    J Magn Reson Imaging; 2004 Apr; 19(4):389-96. PubMed ID: 15065161
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic efficacy of the thymidine kinase/ganciclovir system on large experimental gliomas: a nuclear magnetic resonance imaging study.
    Bouali-Benazzouz R; Lainé M; Vicat JM; Boisseau S; Rémy C; Fouilhé N; Thomas F; Nissou MF; Benabid AL; Berger F
    Gene Ther; 1999 Jun; 6(6):1030-7. PubMed ID: 10455405
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thymidine kinase-mediated killing of rat brain tumors.
    Barba D; Hardin J; Ray J; Gage FH
    J Neurosurg; 1993 Nov; 79(5):729-35. PubMed ID: 8410252
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ganciclovir mediated regression of rat brain tumors expressing the herpes simplex virus thymidine kinase imaged by magnetic resonance.
    Maron A; Gustin T; Mottet I; Demeure R; Octave JN
    J Neurooncol; 1995; 24(3):259-65. PubMed ID: 7595756
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
    Smythe WR; Hwang HC; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM
    Cancer Res; 1994 Apr; 54(8):2055-9. PubMed ID: 8174104
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
    Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S
    Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene.
    Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
    Oncology; 2005; 69(6):503-8. PubMed ID: 16424680
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Timing of ganciclovir administration in glioma gene therapy using HSVtk gene-transduced mesenchymal stem cells.
    Amano S; Gu C; Koizumi S; Tokuyama T; Namba H
    Cancer Genomics Proteomics; 2011; 8(5):245-50. PubMed ID: 21980039
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
    Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
    Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
    Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy.
    Pacholska A; Wirth T; Samaranayake H; Pikkarainen J; Ahmad F; Ylä-Herttuala S
    Cancer Gene Ther; 2012 Dec; 19(12):870-4. PubMed ID: 23079672
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.
    Westphal M; Ylä-Herttuala S; Martin J; Warnke P; Menei P; Eckland D; Kinley J; Kay R; Ram Z;
    Lancet Oncol; 2013 Aug; 14(9):823-33. PubMed ID: 23850491
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.
    Chen SH; Shine HD; Goodman JC; Grossman RG; Woo SL
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3054-7. PubMed ID: 8159705
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
    Ram Z; Culver KW; Walbridge S; Frank JA; Blaese RM; Oldfield EH
    J Neurosurg; 1993 Sep; 79(3):400-7. PubMed ID: 8395592
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
    Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
    Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
    Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
    Packer RJ; Raffel C; Villablanca JG; Tonn JC; Burdach SE; Burger K; LaFond D; McComb JG; Cogen PH; Vezina G; Kapcala LP
    J Neurosurg; 2000 Feb; 92(2):249-54. PubMed ID: 10659011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.